Cornea Transplant in India: Cost, Success Rate & Guide for Foreign Patients 2026

For patients with keratoconus, corneal scarring, endothelial failure, or corneal blindness from infection, cornea transplant in India cost and success rate for foreign patients are among the most searched medical tourism questions — and for good reason. A corneal graft that costs $13,000–$25,000 in the United States can be performed at an accredited Indian eye hospital for $1,000–$3,500, with graft survival rates at five years of 85–95%. India's large donor eye bank network, high surgical volumes, and internationally trained corneal surgeons make it the most cost-effective destination globally for this procedure.
TL;DR: Cornea transplant in India costs $1,000–$3,500 for international patients depending on the technique (PKP, DALK, DSAEK, or DMEK). Graft survival at 5 years: 85–95%. Typical India stay: 2–3 weeks. India's savings versus the US or UK on this procedure are $10,000–$22,000 per eye.
What Is a Cornea Transplant?
The cornea is the transparent dome at the front of the eye that refracts incoming light. When it becomes cloudy, scarred, or structurally unstable, vision deteriorates or is lost entirely. A corneal transplant — medically called keratoplasty — replaces diseased or damaged corneal tissue with healthy donor tissue from a deceased donor's eye.
There are four main techniques, each suited to different underlying conditions:
PKP (Penetrating Keratoplasty): The traditional full-thickness transplant — the entire cornea is replaced. Used for deep stromal scars, advanced keratoconus, and perforations. Recovery is slower (12–18 months for stable vision) but it remains the most versatile option. Cost in India: $1,800–$3,500.
DALK (Deep Anterior Lamellar Keratoplasty): Replaces all layers of the cornea except the innermost endothelium, which is left in place. Indicated for keratoconus, stromal scars, and anterior corneal disease when the patient's own endothelium is healthy. Lower rejection risk than PKP and preferred for younger patients. Cost in India: $1,500–$3,000.
DSAEK (Descemet Stripping Automated Endothelial Keratoplasty): Transplants only the back layers of the cornea — the Descemet membrane and endothelium — for patients with endothelial failure conditions such as Fuchs' endothelial dystrophy or bullous keratopathy. Faster visual recovery than PKP. Cost in India: $1,200–$2,500.
DMEK (Descemet Membrane Endothelial Keratoplasty): The most selective technique, transplanting only the Descemet membrane and endothelial cell layer — a tissue approximately 10–15 microns thick. Provides the fastest and sharpest visual recovery for endothelial disease but is technically demanding. Not all centres offer it. Cost in India: $1,500–$2,800.
Why India for Cornea Transplant?
India's eye care infrastructure is genuinely world-class at the specialist level. The L V Prasad Eye Institute in Hyderabad is a WHO Collaborating Centre for Prevention of Blindness and performs more corneal transplants than almost any other institution in Asia. Sankara Nethralaya in Chennai, Aravind Eye Care System, and Narayana Nethralaya in Bangalore all have dedicated cornea services with high annual surgical volumes and active research programs.
India has over 600 registered eye banks, the largest network in Asia, run under the National Eye Bank guidelines set by the Eye Bank Association of India. Donor graft waiting times at major centres are typically 2–8 weeks — far shorter than in many East and West African countries where cornea donation programs are still developing. Emergency grafts for perforating corneal ulcers can often be sourced within 24–48 hours at specialist institutes.
Corneal surgeons at these centres complete additional fellowship training in cornea and external disease — frequently at institutions in the US, UK, or Australia — before returning to India. The combination of high case volumes (some surgeons perform 300–500 corneal grafts per year) and rigorous subspecialty training produces outcomes that are consistent with the best international benchmarks.
For a broader overview of India's ophthalmology infrastructure and what the country offers across all eye conditions, see our guide to ophthalmology in India.
Cornea Transplant Cost in India for Foreign Patients
The table below compares corneal transplant costs across major healthcare markets. Indian prices are for international patients at accredited private eye hospitals and include surgery, donor graft fee, anaesthesia, hospital stay of 1–3 days, and post-operative medications for the hospital phase.
| Procedure | India | South Africa | UK (Private) | USA |
|---|---|---|---|---|
| PKP (full-thickness) | $1,800–$3,500 | $8,000–$14,000 | $10,000–$18,000 | $15,000–$25,000 |
| DALK | $1,500–$3,000 | $7,000–$13,000 | $9,000–$16,000 | $13,000–$22,000 |
| DSAEK | $1,200–$2,500 | $6,500–$12,000 | $8,500–$15,000 | $12,000–$20,000 |
| DMEK | $1,500–$2,800 | $7,500–$14,000 | $10,000–$18,000 | $13,000–$23,000 |
Typically included in the Indian hospital package price:
- Pre-operative slit-lamp examination, corneal topography, OCT anterior segment, and blood tests
- Surgeon fee, anaesthetist fee, and operating theatre charges
- Donor cornea graft fee (processed through a registered Indian eye bank)
- Hospital stay of 1–3 days in a private room
- Steroid eye drops and medications during the hospital phase
- Post-operative follow-up consultations before discharge
Typically not included:
- Long-haul flight and accommodation outside the hospital
- Immunosuppressive eye drops for ongoing use at home (typically $30–80/month in India if purchased before departure)
- Additional investigations if complications arise
Success Rates and Outcomes
Corneal transplant success rates at major Indian eye institutes are consistent with published international data:
- PKP graft survival: 85–90% at 5 years for keratoconus (best prognosis), 70–80% for other indications
- DALK: 90–95% at 5 years, with lower rejection risk than PKP because the host endothelium is retained
- DSAEK: 80–90% at 5 years; endothelial cell loss is the primary limiting factor
- DMEK: 85–92% at 3 years with excellent visual acuity recovery; technically challenging but best visual outcomes for Fuchs' dystrophy
India's high-volume centres report rejection episode rates that are comparable to or lower than published Western series — largely because patients at specialist institutes receive structured follow-up and are trained in recognising rejection symptoms early. Immediate treatment with intensive topical steroids reverses the majority of acute rejection episodes when caught within 48–72 hours.
The primary risk factor for graft failure globally is corneal allograft rejection. Patients must understand that long-term topical steroid eye drops — often for at least one year post-surgery, sometimes indefinitely — are essential for graft survival, and must be continued after returning home.
How to Choose the Right Hospital
Not all eye hospitals offering corneal transplants in India are equivalent. When evaluating options, prioritise the following:
Annual corneal transplant volume: A centre performing fewer than 100 grafts per year is not comparable to a specialist institute doing 500–1,000. Ask specifically how many transplants the proposed surgeon performs annually.
Eye bank affiliation: Confirm the hospital has direct affiliation with a licensed, active eye bank. Ask about typical graft waiting times for your diagnosis.
NABH or JCI accreditation: Mandatory for international patients. Accreditation ensures infection control, quality standards, and documented patient safety protocols.
Subspecialist cornea surgeon: Confirm your surgery will be performed by a cornea and external disease subspecialist, not a general ophthalmologist. Ask about their fellowship training.
International patient infrastructure: A hospital managing international patients should have a dedicated coordinator who handles visa letters, pre-trip record review, interpreter services, and accommodation referrals.
Leading centres for cornea transplant in India include Sankara Nethralaya (Chennai), L V Prasad Eye Institute (Hyderabad, Bhubaneswar, Vijayawada), Aravind Eye Care System (Coimbatore, Chennai, Madurai), and Narayana Nethralaya (Bangalore).
What to Expect: Step-by-Step Process
Step 1 — Send your records. Share your current corneal topography, anterior segment OCT, slit-lamp photographs, and diagnosis with an Arodya coordinator. If you have these investigations from your local ophthalmologist, they are sufficient for a preliminary review. If not, your Indian hospital can advise on which investigations to have done locally before travel.
Step 2 — Remote pre-operative consultation. Your assigned corneal surgeon reviews your records and conducts a video consultation to confirm the surgical plan, discuss technique choice (PKP vs DALK vs DSAEK/DMEK), and answer your questions. Eye bank graft availability is confirmed at this stage.
Step 3 — Medical visa and travel. Obtain an Indian e-Medical Visa (indianvisaonline.gov.in). Your hospital issues the appointment letter. Processing takes 3–5 business days. Fly to Chennai, Hyderabad, or Bangalore depending on your chosen centre.
Step 4 — Pre-operative assessment. On arrival, a full pre-operative workup is completed: slit-lamp examination, corneal topography, anterior segment OCT, biometry, and systemic fitness assessment. Surgical date is confirmed.
Step 5 — Surgery. The procedure is performed under local anaesthesia (topical drops and/or a peribulbar block) or light sedation. Operating time varies: PKP takes 45–75 minutes; DMEK can take 60–90 minutes in experienced hands. You are discharged after 1–2 nights for routine cases.
Step 6 — Post-operative monitoring in India. The two weeks following surgery are the most critical for monitoring. Steroid eye drop schedules, wound integrity checks, and slit-lamp assessments for early rejection signs are done at the hospital. Do not plan to fly home in less than 14 days after surgery.
Recovery Timeline After Surgery
Recovery timelines vary significantly by technique:
| Milestone | PKP | DALK | DSAEK | DMEK |
|---|---|---|---|---|
| Initial vision (blurry but functional) | 4–8 weeks | 4–8 weeks | 1–4 weeks | 1–3 weeks |
| Stable vision for glasses/contact lens fitting | 12–18 months | 9–15 months | 3–6 months | 2–4 months |
| Suture removal (if applicable) | 12–18 months | 9–12 months | Not required | Not required |
| Safe to fly home | 14–21 days | 14–21 days | 10–14 days | 10–14 days |
| Return to work (desk-based) | 4–6 weeks | 4–6 weeks | 2–4 weeks | 2–3 weeks |
Ananya Krishnan notes that the single most common reason for graft failure in patients who have returned to their home countries is non-compliance with the steroid eye drop schedule — either because the drops are unavailable locally or because patients stop using them once the eye feels comfortable. Before leaving India, ensure you carry at least a 3-month supply of prednisolone acetate eye drops and have a follow-up plan with an ophthalmologist at home who can continue monitoring.
Why African Patients Choose India for Eye Care
Corneal blindness is one of the most treatable causes of vision loss globally, yet it disproportionately affects people in sub-Saharan Africa — where infectious keratitis from onchocerciasis, trachoma, and trauma is common, and where local access to corneal transplantation is extremely limited. In most Nigerian, Kenyan, Ghanaian, Ethiopian, Rwandan, and Tanzanian cities, corneal transplant surgery is either unavailable or has prohibitively long waiting lists for donor tissue.
India offers a rare combination for African patients: affordable surgery ($1,000–$3,500 versus $10,000+ in South Africa), accessible donor grafts through an established eye bank system, English-speaking staff, direct flight connections through hubs like Addis Ababa (Ethiopian Airlines) and Dubai (Emirates and Kenya Airways), and hospitals experienced in managing patients from across the African continent.
The cost of the entire trip — surgery, hospital stay, accommodation for 3 weeks, and return flights from Lagos, Nairobi, Accra, or Addis Ababa — typically totals $4,000–$7,000, compared to $15,000–$25,000 for the surgery alone in the US or Europe. For a patient who has been told there is no local option, this represents a genuine, accessible path to restored vision.
If you are living with corneal disease and have been advised that a transplant may be needed, start by sharing your records with Arodya via the intake form. A corneal surgeon review, graft availability check, and indicative cost quote can be arranged within 5–7 days — at no cost to you. For first-time travellers to India for treatment, our step-by-step planning guide covers visas, flights, accommodation, and what to expect on arrival.




